American College Of Rheumatology

Twelve years is a long time by most measures, but in a field has rapidly changing as lupus nephritis research, it may as well be an eternity.

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable divergence with the recommended dosages of urate-lowering therapies, according to survey data.

Although artificial intelligence presents “exciting opportunities,” its use in patient care “must be regulated” to address biases in decision making, said newly appointed American College of Rheumatology President Carol Langford, MD, MHS.

Money talks. And in the world of medicine, what it has to say has important implications for patients and providers alike.

I have just returned and am recovering from #ACR24, and although there is a universe of things happening in our field, I want to focus for a moment on a rare, marginalized disease with a patient population desperately seeking effective care.

WASHINGTON — Rising rates of ACR20 response in the placebo arms of rheumatoid arthritis trials may be related to increasingly globalized recruitment patterns, according to data presented at ACR Convergence 2024.

WASHINGTON — Early triple therapy may be the most effective strategy for lupus nephritis, according to the new 2024 American College of Rheumatology Guideline for the Screening, Treatment, and Management of Lupus Nephritis.

Only 49.1% of available pediatric rheumatology fellowship slots were filled for 2025 on this year’s Match Day, representing a sharper drop-off for the specialty after years of trickling declines.

The American College of Rheumatology has joined a coalition of more than 40 other organizations calling on congressional leaders to address what they see as insufficient Medicare reimbursements for biosimilars.